Year |
Citation |
Score |
2010 |
Paulnock DM, Freeman BE, Mansfield JM. Modulation of innate immunity by African trypanosomes. Parasitology. 137: 2051-63. PMID 21087532 DOI: 10.1017/S0031182010001460 |
0.706 |
|
2009 |
Dagenais TR, Freeman BE, Demick KP, Paulnock DM, Mansfield JM. Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis. Journal of Immunology (Baltimore, Md. : 1950). 183: 3344-55. PMID 19675169 DOI: 10.4049/Jimmunol.0802005 |
0.718 |
|
2009 |
Dagenais TR, Demick KP, Bangs JD, Forest KT, Paulnock DM, Mansfield JM. T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions. Infection and Immunity. 77: 141-51. PMID 18936180 DOI: 10.1128/Iai.00729-08 |
0.624 |
|
2008 |
Lopez R, Demick KP, Mansfield JM, Paulnock DM. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. Journal of Immunology (Baltimore, Md. : 1950). 181: 4908-17. PMID 18802094 DOI: 10.4049/Jimmunol.181.7.4908 |
0.655 |
|
2007 |
Leppert BJ, Mansfield JM, Paulnock DM. The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling. Journal of Immunology (Baltimore, Md. : 1950). 179: 548-56. PMID 17579076 DOI: 10.4049/Jimmunol.179.1.548 |
0.687 |
|
2007 |
Harris TH, Mansfield JM, Paulnock DM. CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes. Infection and Immunity. 75: 2366-73. PMID 17339353 DOI: 10.1128/Iai.01649-06 |
0.677 |
|
2006 |
Harris TH, Cooney NM, Mansfield JM, Paulnock DM. Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA. Infection and Immunity. 74: 4530-7. PMID 16861639 DOI: 10.1128/Iai.01938-05 |
0.667 |
|
2006 |
Lum HD, Buhtoiarov IN, Schmidt BE, Berke G, Paulnock DM, Sondel PM, Rakhmilevich AL. Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha. Immunology. 118: 261-70. PMID 16771862 DOI: 10.1111/J.1365-2567.2006.02366.X |
0.397 |
|
2005 |
Mansfield JM, Paulnock DM. Regulation of innate and acquired immunity in African trypanosomiasis. Parasite Immunology. 27: 361-71. PMID 16179030 DOI: 10.1111/j.1365-3024.2005.00791.x |
0.379 |
|
2005 |
Buhtoiarov IN, Lum H, Berke G, Paulnock DM, Sondel PM, Rakhmilevich AL. CD40 ligation activates murine macrophages via an IFN-gamma-dependent mechanism resulting in tumor cell destruction in vitro. Journal of Immunology (Baltimore, Md. : 1950). 174: 6013-22. PMID 15879094 DOI: 10.4049/Jimmunol.174.10.6013 |
0.375 |
|
2003 |
Coller SP, Mansfield JM, Paulnock DM. Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-gamma-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. Journal of Immunology (Baltimore, Md. : 1950). 171: 1466-72. PMID 12874239 DOI: 10.4049/Jimmunol.171.3.1466 |
0.781 |
|
2001 |
Coller SP, Paulnock DM. Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. Journal of Leukocyte Biology. 70: 142-8. PMID 11435497 DOI: 10.1189/Jlb.70.1.142 |
0.755 |
|
2001 |
Paulnock DM, Coller SP. Analysis of macrophage activation in African trypanosomiasis. Journal of Leukocyte Biology. 69: 685-90. PMID 11358974 DOI: 10.1189/Jlb.69.5.685 |
0.774 |
|
2000 |
Paulnock DM, Demick KP, Coller SP. Analysis of interferon-gamma-dependent and -independent pathways of macrophage activation. Journal of Leukocyte Biology. 67: 677-82. PMID 10811008 DOI: 10.1002/Jlb.67.5.677 |
0.78 |
|
1998 |
Lokuta MA, McDowell MA, Paulnock DM. Identification of an additional isoform of STAT5 expressed in immature macrophages. Journal of Immunology (Baltimore, Md. : 1950). 161: 1594-7. PMID 9712020 |
0.586 |
|
1998 |
Lucas DM, Lokuta MA, McDowell MA, Doan JE, Paulnock DM. Analysis of the IFN-gamma-signaling pathway in macrophages at different stages of maturation. Journal of Immunology (Baltimore, Md. : 1950). 160: 4337-42. PMID 9574537 |
0.691 |
|
1995 |
McDowell MA, Lucas DM, Nicolet CM, Paulnock DM. Differential utilization of IFN-gamma-responsive elements in two maturationally distinct macrophage cell lines. Journal of Immunology (Baltimore, Md. : 1950). 155: 4933-8. PMID 7594498 |
0.65 |
|
1994 |
Nicolet CM, Paulnock DM. Promoter analysis of an interferon-inducible gene associated with macrophage activation. Journal of Immunology (Baltimore, Md. : 1950). 152: 153-62. PMID 8254188 |
0.4 |
|
1994 |
Paulnock DM. The molecular biology of macrophage activation. Immunology Series. 60: 47-62. PMID 8251587 |
0.345 |
|
1992 |
Paulnock DM. Macrophage activation by T cells. Current Opinion in Immunology. 4: 344-9. PMID 1418715 DOI: 10.1016/0952-7915(92)90087-U |
0.415 |
|
1992 |
Wynn TA, Freund YR, Paulnock DM. TNF-alpha differentially regulates Ia antigen expression and macrophage tumoricidal activity in two murine macrophage cell lines. Cellular Immunology. 140: 184-96. PMID 1310901 DOI: 10.1016/0008-8749(92)90186-S |
0.45 |
|
1991 |
Wynn TA, Nicolet CM, Paulnock DM. Identification and characterization of a new gene family induced during macrophage activation. Journal of Immunology (Baltimore, Md. : 1950). 147: 4384-92. PMID 1753106 |
0.389 |
|
1990 |
Haak-Frendscho M, Wynn TA, Czuprynski CJ, Paulnock D. Transforming growth factor-beta 1 inhibits activation of macrophage cell line RAW 264.7 for cell killing. Clinical and Experimental Immunology. 82: 404-10. PMID 2242621 DOI: 10.1111/J.1365-2249.1990.Tb05461.X |
0.386 |
|
1990 |
Paulnock DM, Lambert LE. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. Journal of Immunology (Baltimore, Md. : 1950). 144: 765-73. PMID 2104906 |
0.49 |
|
1989 |
Lambert LE, Paulnock DM. Differential induction of activation markers in macrophage cell lines by interferon-gamma. Cellular Immunology. 120: 401-18. PMID 2541931 DOI: 10.1016/0008-8749(89)90208-6 |
0.504 |
|
1989 |
Guagliardi LE, Byrne GI, Paulnock DM. Differential modulation of lymphocyte proliferative responses and lymphokine secretion in mice during development of immunity to Chlamydia psittaci. Infection and Immunity. 57: 1561-7. PMID 2496033 DOI: 10.1128/Iai.57.5.1561-1567.1989 |
0.352 |
|
1988 |
Byrne GI, Guagliardi LE, Huebner RE, Paulnock DM. Immunomodulation and Chlamydia: immunosuppression and the protective immune response to C. psittaci in mice. Advances in Experimental Medicine and Biology. 239: 343-52. PMID 3059773 DOI: 10.1007/978-1-4757-5421-6_33 |
0.301 |
|
1988 |
Spear GT, Paulnock DM, Helgeson DO, Borden EC. Requirement of differentiative signals of both interferon-gamma and 1,25-dihydroxyvitamin D3 for induction and secretion of interleukin-1 by HL-60 cells. Cancer Research. 48: 1740-4. PMID 2832052 |
0.343 |
|
1987 |
Lambert LE, Paulnock DM. Modulation of macrophage function by gamma-irradiation. Acquisition of the primed cell intermediate stage of the macrophage tumoricidal activation pathway. Journal of Immunology (Baltimore, Md. : 1950). 139: 2834-41. PMID 3116096 |
0.498 |
|
Show low-probability matches. |